Rekombinanter TNFSF4 (Oxelumab Biosimilar) Antikörper

Produktnummer ABIN5564244

Der Human-Monoklonal Anti-TNFSF4 (Oxelumab Biosimilar)-Antikörper wurde für FACS und Func validiert. Er ist geeignet zum Nachweis von TNFSF4 (Oxelumab Biosimilar) in Proben aus Human. }

Kurzübersicht für Rekombinanter TNFSF4 (Oxelumab Biosimilar) Antikörper (ABIN5564244)

Target: TNFSF4 (Oxelumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Human

Klonalität: Monoklonal

Konjugat: Dieser TNFSF4 (Oxelumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Functional Studies (Func)

Klon: R4930

Produktdetails anti-TNFSF4 (Oxelumab Biosimilar) Antikörper

Spezifität: Recognizes human OX40L.

Kreuzreaktivität: Human

Reinheit: >95 % (SDS-PAGE)

Endotoxin-Niveau: <0.001EU/μg

Immunogen: Recombinant human OX40L.

Isotyp: IgG1

Anwendungsinformationen

Kommentare:

This antibody is a biosimilar generically called Oxelumab (CAS 1186098-83-8) and originally developed by Genentech. Oxelumab is a OX40 ligand blocker designed for the prevention of allergen-induced airway inflammation in adults with mild asthma. Potentially other application areas are transplantation and autoimmunity research or protection against inflammation-driven fibrosis.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: In PBS.

Konservierungsmittel: Without preservative

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 year after receipt when stored at -20°C. Stable for at least 3 months after receipt when stored at +4°C.

Haltbarkeit: 12 months

Details zu TNFSF4 (Oxelumab Biosimilar)

Target: TNFSF4 (Oxelumab Biosimilar)

Substanzklasse: Biosimilar

Hintergrund: OX40L is a membrane-expressed cytokine that belongs to the TNF ligand family. It acts as costimulator through interaction with its ligand OX40 on T cells, stimulating T cell activation, proliferation and cytokine production. OX40L is expressed on antigen presenting cells including B cells, dendritic cells, mast cells and endothelium.

UniProt: P23510